The suppressive function of regulatory T cells (T reg ) is impaired in multiple sclerosis (MS) patients. The mechanism underlying the T reg functional defect is unknown. T reg mature in the thymus and the majority of cells circulating in the periphery rapidly adopt a memory phenotype. Because our own previous findings suggest that the thymic output of T cells is impaired in MS, we hypothesized that an altered T reg generation may contribute to the suppressive deficiency. We therefore determined the role of T reg that enter the circulation as recent thymic emigrants (RTE) and, unlike their CD45RO ؉ memory counterparts, express CD31 as typical surface marker. We show that the numbers of CD31 ؉ -coexpressing CD4
G rowing evidence suggests a role for natural immunoregulatory T cells of the CD4
ϩ CD25 ϩ FOXP3 ϩ phenotype (T reg ) 3 in the prevention of autoimmunity. Numerous studies have reported numeric or functional deficiencies of T reg in various human autoimmune diseases including inflammatory demyelinating disorders of the CNS (Refs. 1-10 and M. Korporal, M., J. Haas, B. Fritzsching, S. Möller, B. Fritz, C. S. Falk, P. H. Krammer, E. Suri-Payer, and B. Wildemann, Restored suppressive capacities of regulatory T cells under therapy with IFN-␤ and glatiramer acetate in patients with multiple sclerosis, submitted for publication). We and others have shown that T reg derived from patients with relapsing remitting multiple sclerosis (RRMS) display a functional impairment because they inhibit myelin-specific and Ag-nonspecific T cell proliferation less potently as compared with healthy control donors (Refs. 8 -10 and M. Korporal, M., J. Haas, B. Fritzsching, S. Mö ller, B. Fritz, C. S. Falk, P. H. Krammer, E. Suri-Payer, and B. Wildemann, submitted for publication). The mechanisms of this T reg defect are unclear. In particular, T reg frequencies in the peripheral blood of multiple sclerosis (MS) patients are unaltered as is their susceptibility to undergoing CD95 ligand-mediated apoptosis (Refs. 8, 10, and 11 and M. Korporal, M., J. Haas, B. Fritzsching, S. Mö ller, B. Fritz, C. S. Falk, P. H. Krammer, E. Suri-Payer, and B. Wildemann, submitted for publication).
T reg mature in the thymus and the majority of the cells rapidly adopt a memory CD45RO phenotype (12) when released into the periphery. However, there is recent evidence that small numbers of T cells with a naive CD4 ϩ CD25 ϩ CD45RA ϩ surface profile and immunosuppressive properties are detectable within the peripheral T reg pool (13) (14) (15) (16) . Unlike their Ag-primed memory counterpart, this naive T reg subset may comprise de novo generated cells that have been recently released from the thymus and have not yet experienced Ag contact. Kimmig et al. have demonstrated that surface expression of CD31 (PECAM-1) on naive CD4 ϩ T cells distinguishes recent thymic emigrants (RTEs) from peripherally expanded naive Th cells (RTE-Th) (17) . CD4 ϩ CD45RA ϩ RO Ϫ CD31 ϩ RTEs, unlike CD45RA ϩ Th cells lacking CD31, contain high amount of TCR excision circles (TRECs). TRECs are generated as a by-product of the TCR rearrangement process in the thymus and are enriched in newly generated T cells (18) . Thus, phenotypic and molecular features define
CD4
ϩ CD45RA ϩ CD31 ϩ T cells as RTEs and CD4 ϩ CD45RA ϩ CD31 Ϫ T cells as peripherally expanded naive Th cells. As thymic function declines with age the release of RTEs also decreases. This loss of de novo generated Th cells is compensated by peripheral postthymic expansion, resulting in an increase of CD4 ϩ CD45RA ϩ CD31 Ϫ T cell numbers with age (17, 19) . This age-related change in the composition of the CD4 ϩ T cell pool may also affect the homeostatic balance and, eventually, the functional properties of T reg . In concordance with this assumption, an age-dependent decline of T reg suppressive potencies has been recently reported in a pilot study (20) . Our own previous work suggests that the thymic export function is impaired in MS as levels of TREC-expressing peripheral T cells are significantly decreased in patients with clinically active RRMS in the absence of an accelerated T cell turnover (21) . Therefore, we hypothesized that an altered T reg homeostasis may contribute to the suppressive deficiency associated with MS.
To elucidate a potential imbalance in T reg homeostasis in MS, we analyzed the role of naive T reg that coexpress CD31 and circulate in the periphery as RTE. We measured the numbers of RTE-T reg within the peripheral blood of patients with RRMS and healthy persons by multicolor flow cytometry analysis and determined their contribution to the suppressive function of the entire T reg population by in vitro proliferation assays. We also performed CDR3 spectratype analysis to screen T reg derived from both cohorts for differences in the TCR repertoire.
Materials and Methods

Subjects
Blood specimens were obtained from 40 RRMS patients (mean age 33.9 years, range 14 -62 years) as well as from 49 healthy controls (HCs) (mean age 36.7 years, range 24 -85 years). All patients had definite MS according to McDonald's or Poser criteria (22, 23) and had experienced an average number of 1.4 previous relapses (range 0 -3). Disease duration ranged between 1 and 5 years (median 2). The mean Expanded Disability Status Scale score was 1.7 (range 1-2). All patients had a clinically active disease and had not yet received treatment with corticosteroids or immunomodulatory agents. The protocol was approved by the University of Heidelberg (Heidelberg, Germany) ethics committee and all individuals gave written informed consent.
Flow cytometry
The mAbs used for flow cytometry were obtained from BD Pharmingen (anti-human CD4, CD45RO, CD45RA, and CD31), Miltenyi Biotech (antihuman CD25), and eBioscience (anti-human FOXP3). FOXP3 staining was performed according to the manufacturer's protocol. For six-color flow cytometric analysis, cells were first stained with a surface mAb specific for CD4, CD25, CD45RO, CD45RA, or CD31 followed by FOXP3 intracellular staining. FACS acquisition was performed immediately with a FACSCanto cytometer and analyzed with FACSDiva software (BD Biosciences (Fig. 1B) . RTE-T reg and RTE-Th were identified by coexpression of the CD31 molecule within the naive T reg and Th subsets (Fig. 1C) .
Cell separation
PBMC were isolated from 50 ml of peripheral blood by density gradient centrifugation using Ficoll/Hypaque (Biochrom). CD4 ϩ T cells were isolated from PBMCs by using a negative CD4 ϩ T cell isolation kit (Dynal Biotech). CD4 ϩ CD25 high T reg and CD4 ϩ CD25 low /CD4 ϩ CD25 int effector T cells (T eff ) were isolated from the pure untouched CD4 ϩ T cells using CD25 magnetic beads (Dynal Biotech). Magnetic beads were removed from T reg using Detachabead CD4 solution (Dynal Biotech). T reg isolated from the PBMC of nine HCs and seven patients were further separated according to their CD31 expression in CD31 ϩ T reg and CD31 Ϫ T reg by the use of a FITC-labeled anti-CD31 mAb and an anti-FITC MultiSort kit (Miltenyi Biotec). Immune magnetic separation constantly yielded highly pure T reg subsets with Ͼ90% CD4 ϩ CD25 high cells as previously described (Ref. 10 
Cell proliferation assay
Freshly isolated T eff (10 5 ) were incubated in 96-well plates (Nunc) in 200 l of culture medium alone or in 4:1 coculture with 2.5 ϫ 10 4 total T reg or T reg subsets. For TCR stimulation, soluble anti-CD3 (1 g/ml) and anti-CD28 mAbs (1 g/ml) were added to the culture medium. After 4 days at 37°C in 5% CO 2 , 1 Ci of [ 3 H]thymidine per well was added for an additional 16 h. Proliferation was measured using a scintillation counter. Inhibition rate (percentage) of T reg in coculture experiments was defined as [1 Ϫ [ 3 H]thymidine uptake (cpm) within a T reg plus T eff coculture Ϭ cpm of T eff alone] ϫ 100. Each experiment was performed in triplicate. The CD3 and CD28 mAbs used for cell culture experiments were purified from hybridoma supernatants by protein A affinity purification as described (25) . Cell culture medium and mAbs were endotoxin free (Ͻ10 pg/ml) as assessed by a Limulus assay (Sigma-Aldrich).
Quantification of TRECs
Genomic DNA was extracted from 2 ϫ 10 5 T reg or T reg subsets by the use of a DNAzol solution (Invitrogen Life Technologies) according to the manufacturer's recommendations. The numbers of TRECs in T cell subsets were determined by real time PCR as described previously (21) . Results were expressed as TRECs per 10 6 cells.
CDR3 spectratyping
We performed CDR3 spectratyping to determine the TCR V␤ repertoire in patient and HC T reg and T eff . Total RNA was isolated from 2 ϫ 10 5 T reg or 10 6 T eff using Absolutely RNA Microprep kit (Stratagene) according to the manufacturer's protocol and converted to cDNA by a SuperScript firststrand synthesis kit (Invitrogen). Amplification of the entire group of 24 TCR V subfamilies was conducted with 24 V␤-specific primers and one FIGURE 2. Purity and phenotype of isolated T reg and T reg subsets. A and B, Immunomagnetically isolated T reg and T reg subsets were stained with mAbs specific for CD4, CD25, CD45RA, CD45RO, CD31, and FOXP3 and analyzed by flow cytometry. A typical staining of T reg subsets immunomagnetically separated from peripheral blood of one healthy donor is shown. More than 92% of isolated T reg , CD31
ϩ T reg , and CD31-depleted T reg were CD4 ϩ CD25 high (A) and FOXP3-positive (B) and therefore were highly pure. C, Approximately 30% of isolated T reg express CD31 on their surface. After further separation of total T reg into CD31 ϩ and CD31 Ϫ cells using CD31-labeled microbeads, Ͼ95% of the CD31 ϩ fraction but only Ͻ1% of the CD31 Ϫ fraction expressed CD31. D, Dot plots show CD45RA vs CD45RO expression, revealing that purified total T reg are predominantly CD45RA Ϫ CD45RO ϩ memory cells (R1) with only 5-10% naive cells (R3). CD31 Ϫ T reg also exhibited a memory phenotype with Ͻ1% of CD45RA ϩ CD45RO Ϫ cells. In contrast, CD31 ϩ T reg were predominantly naive with only Ͻ10% memory cells.
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NAIVE REGULATORY CD4 ϩ CD25 high T CELLS IN MULTIPLE SCLEROSIS primer recognizing the C region (26, 27) . One hundred nanograms of cDNA from each T eff and T reg sample was amplified in eight parallel PCRs each containing a set of three different V␤ primers respectively and the C-primer, which was 6-FAM-labeled for CDR3 spectratyping. Size distribution of fluorescent PCR products was determined by laser-induced capillary electrophoresis using an automated DNA analyzer (A310; Applied Biosystems) and GeneScan software (Applied Biosystems). Normal transcript size distribution consists of eight peaks for each V subfamily (28) . Complexity within a V subfamily was determined by counting the number of peaks per subfamily. The complexity score (CS) was calculated as the summation of the scores of all 24 subfamilies. The maximum score would be 192. 
Statistical analysis
To determine whether differences and correlations in cell counts, inhibitory capacities, TREC levels, and TCR diversities were statistically significant, we performed the Student's t test using a two-tailed distribution with unpaired samples and calculated the Pearson's correlation coefficient. p Ͻ 0.05 was considered significant.
Results
Frequencies of naive Th cells coexpressing CD31 decrease with age and are reduced in the peripheral blood of MS patients
To determine the number of naive helper T cells that have just entered the circulation as RTEs (RTE-Th), we performed multicolor flow cytometric staining of PBMCs obtained from 28 MS patients and 28 age-matched HCs. RTE-Th frequencies were calculated as percentage of CD45RA ϩ CD45RO Ϫ CD31 ϩ cells within total CD4
ϩ FOXP3 Ϫ T cells (Fig. 1) . As expected, the proportions of RTE-Th within CD4
ϩ FOXP3 Ϫ cells declined with age in HCs (Fig. 3A) . In individuals Ͻ30 years of age RTE-Th constituted approximately one-third of CD4 ϩ T cells (mean 28.3%, range 20.9 -37.5%). RTE-Th numbers were significantly lower in persons aged 30 -45 years (mean 22.0%, range 8.9 -33.0%, p ϭ 0.048) and lowest in persons Ͼ45 years of age (mean 16.6%, range 6.5-33.4%, p ϭ 0.001). RTE-Th frequencies in patients were significantly lower than those in HCs (MS patients: mean 18.1%, range 3.5-34.6%; HCs: mean 22.7%, range 6.5-37.5%; p ϭ 0.025, Fig. 3A Fig. 3B ). CD31 expression on memory CD4 ϩ T cells was consistently Ͻ10% and did not differ between MS patients and HCs (data not shown). In concordance with numerous studies and our own previous observations, the distribution of total CD4 ϩ T cells was independent of age and unaltered within peripheral blood samples of MS patients (data not shown).
Frequencies of naive T reg coexpressing CD31 are ageassociated and are reduced in the peripheral blood of MS patients
Next, we screened peripheral blood samples from 28 MS patients and 28 age-matched HCs for the presence of total T reg and T reg subsets by multicolor flow cytometry. Proportions of RTE-T reg were calculated as percentages of CD45RA ϩ CD45RO Ϫ CD31 ϩ cells within total CD4 ϩ FOXP3 ϩ CD25 ϩ cells (Fig. 1) . With regard to total T reg , we observed slightly reduced percentages of CD25 ϩ FOXP3 ϩ cells among total CD4 ϩ T cells in MS patients that were not statistically significant (MS: mean 5.0%, range 1.6 -9.2%; HCs: mean 5.7%, range 2.6 -12.9%; p ϭ 0.107; not depicted). T reg frequencies did not change with age in both patients and HCs (data not shown). In contrast, RTE-T reg frequencies within total FOXP3 ϩ cells declined with age in HCs (all: mean 4.8%, range 0.3-19.5%; Ͻ30 years of age: mean 7.2%, range 1.5-19.5%; 30 -45 years of age: mean 3.1%, range 0.3-6.1%; Ͼ45 years of age: mean 3.2%, range 0.7-6.6%; Fig. 3C ). In patients the proportions of RTE-T reg were significantly reduced and not ageassociated (all: mean 2.7%, range 0.0 -9.8%; Ͻ30 years of age: mean 2.6%, range 0.0 -5.7%; 30 -45 years of ages: mean 3.1%, range 0.4 -9.8%; Ͼ45 years of age: mean 2.4%, range 0.4 -5.9%). Differences in RTE-T reg numbers between MS and HCs were statistically significant for younger persons but were no more detectable in older subjects (Ͻ30 years of age: p ϭ 0.034; 31-45 years of age: p ϭ 0.799; Ͼ45 years of age: p ϭ 0.348; Fig. 3C Fig. 3D ) and were enhanced in younger MS patients. CD31 expression on memory T reg was consistently low in blood samples of both MS patients and HCs (data not shown).
TRECs are detectable in CD31 ϩ T reg but not in CD31 Ϫ T reg
Because TRECs are highly enriched in RTEs (17) as a result of the accomplished TCR gene rearrangement process without further dilution due to proliferation (18), we studied the intracellular levels of TRECs in T reg and T eff subsets isolated from four HCs (mean age 29.0 years, range 26 -41 years of age).
In concordance with our previous findings (10) total T reg had a very low TREC content (mean 1.6 ϫ 10 3 /10 6 cells, range 0.8 -2.5 ϫ 10 3 /10 6 cells), suggesting that the T reg pool in the periphery mainly consists of rapidly dividing memory T reg (Fig. 4) . As expected, TRECs were virtually absent in the purified CD31 Ϫ T reg subset predominantly exhibiting a memory phenotype (mean 0.1 ϫ 10 3 /10 6 cells, range 0.0 -0.1 ϫ 10 3 /10 6 cells). In contrast, mean frequencies of TRECs in CD31 ϩ T reg were substantially higher as compared with the entire T reg population (9.5 ϫ 10 3 /10 6 cells, range 7.1-11.6 ϫ 10 3 /10 6 cells; p Ͻ 0.001), reflecting the more naive status of this distinct T reg subset.
T reg suppressive function is age dependent in healthy individuals
We evaluated the data of proliferation assays performed with T reg and T eff isolated from a total of 89 HC donors and 56 patients. Some were from the present study (HCs: n ϭ 18; MS: n ϭ 14), inhibitory capacities in younger HCs were higher as compared with persons of higher age (Ͻ30 years of age: mean 58.4%, range 10.7-98.4%; 30 -45 years of age: mean 46.0%, range 3.9 -89.5%, p ϭ 0.026; Ͼ45 years of age: mean 40.6%, range 21.2-59.6%; p ϭ 0.018; Fig. 5B ). Such a decline of suppressive capacity was not seen in patients, who showed the same low suppressive capacity in all age groups (Ͻ30 years of age: mean 36.6%, range 0.0 -86.4%; 30 -45 years of age: mean 41.6%, range 0.0 -81.9%; Ͼ45 years of age: mean 41.8%, range 8.5-63.7%; Fig. 5, A and B) . Differences in T reg -mediated suppression between MS patients and HCs were statistically significant for younger persons but were no more detectable in older subjects (Ͻ30 years of age: p ϭ 0.001; 30 -45 years of age: p ϭ 0.369; Ͼ45 years of age: p ϭ 0.520). In contrast with the T reg -mediated suppression rates, the T eff proliferative responses were not age dependent in HCs and did not differ between MS patients and HCs (Fig. 5, C and D) .
Depletion of CD31 ϩ T reg neutralizes the differences in T reg function between MS patients and healthy individuals
To determine whether the T reg suppressive function correlates with the percentage of cells expressing CD31, we obtained T reg and T reg depleted of CD31 ϩ cells from seven patients (mean age 30.7 years) and seven HCs (mean age 28.7 years). Total T reg and CD31 Ϫ T reg were tested in parallel in primary in vitro proliferation assays by 1:4 cocultures with 10 5 TCR-stimulated autologous T eff . As shown above for the entire cohort, again total T reg derived from patients exhibited a reduced inhibitory activity in vitro when compared with T reg isolated from HCs (MS: mean 37.5%, range 19.3-56.1%; HCs, mean 60.0%, range 34.5-83.0%; p ϭ 0.011, Fig. 6A ). CD31 Ϫ T reg obtained from HCs exhibited a less potent inhibitory capacity toward activated T eff with 42.6% (range 8.7-71.8%) suppression only (Fig. 6A ). This inhibition rate was comparable to patient-derived CD31 Ϫ T reg , which inhibited T eff proliferation to the same extent compared with total T reg (38.7%, range 25.9 -59.0%; p ϭ 0.837).
Thus, the difference in inhibitory potencies of patient and HC T reg cells detectable when using total T reg in the coculture experiments was neutralized by the depletion of CD31 ϩ cells. From 16 subjects (MS: n ϭ 6; HCs: n ϭ 10) parallel data from both primary in vitro proliferation assays and multicolor flow cytometry were available. When the percentage of inhibition was plotted against the percentage of RTE-T reg a clear correlation between T reg suppressive capacities and the prevalence of RTE-T reg was obtained (r ϭ 0.553; Fig. 6B ).
TCR-diversity of T reg is contracted in MS
To analyze, whether an altered de novo generation of T reg also influences the T reg clonal distribution, we determined the CDR3 spectratype CS to compare the TCR diversity of T reg from MS patients and HCs (Fig. 7) . The mean CS of T reg obtained from 22 HCs was 161 (range 138 -185). CDR3 spectratyping of patient-T reg (n ϭ 24) resulted in lower CS values (mean 151, range 101-173). The difference of complexity scores between both study cohorts was statistically significant, with p ϭ 0.041.
Discussion
In previous work, we and others have demonstrated that T reg from MS patients are functionally impaired (Refs. 8 -10 and M. Korporal, M., J. Haas, B. Fritzsching, S. Möller, B. Fritz, C. S. Falk, P. H. Krammer, E. Suri-Payer, and B. Wildemann, submitted for publication). In the present study we provide evidence that the diminished suppressive T reg potencies in MS are related to disequilibrium in the homeostatic composition of circulating T reg and most likely result from an altered thymic release of newly formed T cells into the periphery. Because T reg frequencies in peripheral blood are normal in MS patients as reported in a number of independent studies (Refs. 8 -10 and M. Korporal, M., J. Haas, B. Fritzsching, S. Möller, B. Fritz, C. S. Falk, P. H. Krammer, E. Suri-Payer, and B. Wildemann, submitted for publication) and the susceptibility of patient-derived T reg to undergo apoptotic cell death is also unaltered (11), we wondered whether any imbalance in T cell neogenesis contributes to the T reg defect detectable in MS patients. The rationale to assess this issue in more detail was based on our earlier observation that the thymic export function and the ability to maintain T cell homeostasis is disturbed in MS (21) . This may also affect T reg , which is generated in the thymus as a naturally suppressive T cell subset. Kimmig et al. showed that only naive CD4
ϩ CD45RA ϩ cells coexpressing CD31 harbor extrachromosomal deletion circles as traceable molecular markers of newly generated T lymphocytes and phenotypically define RTE (17) . The prevalence of CD4 ϩ CD45RA ϩ CD31 ϩ cells declines with age, reflecting the thymic-dependent neogenesis of this subset (17, 19) . In the present work we confirmed these findings, because the proportion of CD45RA ϩ CD45RO Ϫ CD31 ϩ cells within the peripheral CD4 ϩ FOXP3 Ϫ Th pool decreased with age whereas pure CD4 ϩ T cell numbers remained at constant levels. Moreover, the frequencies of CD4 ϩ FOXP3 Ϫ CD45RA ϩ CD45RO Ϫ CD31 ϩ cells were significantly decreased in peripheral blood samples of MS patients, thus establishing the presence of an age-inappropriately reduced neogenesis of CD4 ϩ FOXP3 Ϫ Th cells in MS. In concordance with our present and previous results, decreased levels of naive CD4 ϩ T cells in MS were also reported by Crucian et al. (29) and recently by Duszczyszyn and coworkers (30) . To demonstrate that the altered Th homeostasis also affects the T reg compartment, we analyzed the CD4 ϩ FOXP3 ϩ cells of patient and control-derived PBMCs. In striking contrast to the total T reg quantities that were unaltered in MS, the subpopulation of naive T reg coexpressing CD31 was markedly reduced in patient-derived peripheral blood specimens, with most prominent alterations in younger subjects. This T reg subset encompasses up to 20% of the entire T reg pool and is phenotypically defined by the expression of CD4, CD25, FOXP3, CD45RA, and CD31. CD45RA ϩ CD45RO Ϫ CD31 ϩ T reg decline with age in healthy persons and, unlike their CD31 Ϫ "memory-T reg " counterparts, harbor TRECs. Therefore, they are most likely naive T reg recently released from the thymus and are denoted here as "RTE-T reg ." The reduced de novo generation of RTE-T reg in MS occurred independently of clinical parameters, including an expanded disability status scale score, disease duration, and number of relapses, and was compensated by higher proportions of CD45RA Ϫ CD45RO ϩ FOXP3 ϩ cells resulting in a stable cell count of the total T reg population.
This shift from naive toward memory T reg is also detectable in healthy elder individuals. In MS patients the lower levels of RTE-T reg coincide with a moderately contracted T reg TCR V␤ repertoire. Together with our observation that the T reg inhibitory function seems to be reduced in age, which was also reported previously in a small number of healthy individuals (20) , this raised the possibility that the prevalence of RTE-T reg critically affects total T reg function. Accordingly, the comparative functional analysis of total T reg and T reg subsets revealed differing suppressive abilities. When assessing immunomagnetically separated total CD25 high T reg , we found the expected functional defect in T reg obtained from MS patients. Interestingly, the difference in T reg -mediated suppression between patient and control-derived T reg was totally neutralized when T reg depleted of CD31 ϩ cells were used in the coculture assays. The absence of CD31 ϩ cells markedly reduced the inhibition of T cell proliferation mediated by donor T reg but had no effect on the suppressive function of patient T reg . Overall, there was a clear correlation between T reg -mediated suppression and the prevalence of RTE-T reg within the T reg pool. Taken together, this clearly indicates that CD31-expressing naive T reg contribute to the functional properties of the entire T reg population and further illustrates the obvious lack of RTE-T reg in MS patients.
Fritzsching et al. recently reported that human naive T reg are less sensitive to apoptotic cell death as compared with conventional T reg and suggested that naive T reg are in an earlier state of differentiation whereas "classic" memory T reg represent fully mature suppressor cells, which can be easily eliminated by apoptotic signals from conventional T cells (16) . Moreover, in vitro expansion of human naive T reg , but not memory T reg , generates fully suppressive T reg clones as recently demonstrated (31) . Therefore, although it seems counterintuitive, it is possible that also in vivo the naive or especially the CD31 ϩ CD45RA ϩ T reg compartment exerts the most effective suppression. In contrast, preactivated T reg might be exhausted, prone to apoptosis, and less effective in suppression. This idea should be addressed in additional experiments in murine models.
Thus, we claim, that CD45RA ϩ CD45RO Ϫ CD31 ϩ T reg represent a group of immature, natural regulatory T cells recently released from the thymus that are characterized by normal suppressive potential and insensitivity against apoptotic elimination. A constant supply of RTE-T reg may be essential to compensate exhausted or eliminated memory T reg and to maintain full inhibitory capacity of the entire T reg compartment. Any down-regulation of RTE-T reg release in the context of physiological thymic atrophy or pathological processes may impair T reg homeostasis in the periphery and is likely to promote alterations in T reg function in magnitudes that are detectable in elderly individuals and also in MS patients. Concordant with homeostatic shifts within the T reg subset, Vukmanovic-Stejic et al. recently described a population of short-lived memory T reg induced from primed/memory CD4 ϩ CD25 Ϫ T cells in the periphery that, via rapid peripheral turnover, is responsible for the maintenance of T reg numbers during aging (32) .
The reconstitution of T reg homeostasis either by adoptive transfer of naive T reg or by modulation of thymic function should have the potential to restore the impaired T reg suppressive capacities in MS patients back to normal levels.
We have recently shown that prolonged treatment of MS patients with glatiramer acetate (GA) and IFN-␤ restores T reg function via a direct targeting of the T reg compartment (M. Korporal, M., J. Haas, B. Fritzsching, S. Möller, B. Fritz, C. S. Falk, P. H. Krammer, E. Suri-Payer, and B. Wildemann, submitted for publication). In addition to their anti-inflammatory effects (33, 34) , immunomodulatory drugs, including GA, up-regulate numbers of naive T cells in MS patients (35, 36) . Our own preliminary data indicate that RTE-T reg numbers increase under GA treatment (data not shown) and possibly suggest a direct effect of this agent on thymic function. Therefore, we believe that pharmacologic modulation of the thymus and the reconstruction of peripheral T reg homeostasis may trigger the augmentation of T reg inhibitory capacities and may be a promising treatment strategy in MS and other autoimmune disorders.
